ISPPP 2014

Keynote Speakers

Michel Eppink, Synthon Biopharmaceuticals BV, Nijmegen/NL
Antibody Drug Conjugates: a new platform of protein therapeutic molecules

Klaus Graumann, Sandoz GmbH, Kundl/A
Technical development aspects for biosimilars

Jürgen Hubbuch, Karlsruhe Institute of Technology/D
High throughput process development - screening, analytics and modeling

Todd Przybycien, Carnegie Mellon University, Pittsburgh, PA/USA
Affinity chromatography with PEGylated protein ligands

Date and time of the keynote lectures is given in the ISPPP 2014 programme

Renowned international keynote speakers at ISPPP 2014 conference.
Jetzt Mitglied werden